VTRS
Viatris
Pharmaceutical Preparations · Health Care
$18.92+1.34%
Quote via Yahoo Finance, may be delayed · 2026-11-03 · 4:00 PM ET
Daily prices: Yahoo Finance, split-adjusted. As of 2026-11-03.
Drag across the line to read a price. Dots mark earnings, filings and dividends.
Weak profile
12-1 month return lifts this profile the most.
As of 2025-12-31. Latest quarter ended 2026-06-30. v1 methodology, subject to change.
The profile score is 10 points lower since last quarter. Debt and safety is 14 points lower. Profits is 11 points lower.
Sector rank 39 of 46
In plain English
- Viatris operates in Pharmaceutical Preparations.
- Latest-year revenue was 14.3 billion.
- The profile score is 41, a Weak profile. Momentum is the strongest listed input.
Written from the figures on this page. No language model was called. It may still be wrong. Not advice.
As of 2025-12-31. Latest quarter ended 2026-06-30. SEC EDGAR companyfacts, fetched 2026-11-01. SEC filing
Financials
Tap a column to read the value.
P/E vs own history
Not shown while earnings are negative.
Data confidence
The Company Score summarises financial characteristics relative to similar companies using a published formula. It does not predict future returns.
SEC EDGAR companyfacts, fetched 2026-11-01.